无家可归和癌症:一个多地点,混合方法研究延迟或没有癌症治疗
Robert J Haemmerle1, Kelliann Fee-Schroeder2, Lynn Phelan2
1Department of Medicine, Mayo Clinic, Rochester, MN, USA.
The American journal of hospice & palliative care
|March 18, 2025
概括
对于无家可归的患者来说,由于沟通障碍和后勤挑战,癌症治疗经常被推迟. 解决这些问题,比如提供电话,可以改善及时的癌症护理.
科学领域:
- 在瘤学瘤学.
- 公共卫生 公共卫生
- 医疗保健服务研究 医疗服务研究
背景情况:
- 无家可归的患者往往面临着因治疗延迟而导致的癌症不良结果.
- 有限的混合方法研究存在于患者和医疗保健工作人员层面的因素导致这些延迟.
研究的目的:
- 调查患者和医疗保健工作人员层面的因素,导致无家可归的患者癌症治疗延迟.
- 确定在该人群中及时启动癌症护理的具体障碍和促进因素.
主要方法:
- 一个单一机构,多个地点的研究分析了从2019年1月到2023年10月的医疗记录.
- 来自数千名患者记录的定量和定性数据被严格分析.
- 专注于43名患有癌症的无家可归患者.
主要成果:
- 63%的患者 (27在43) 经历了超过4周的癌症治疗延迟.
- 癌症治疗开始的中位时间为9周.
- 关键障碍包括沟通挑战 (例如,缺乏电话接入),患者不情愿和医疗复杂性.
结论:
- 对于无家可归的患者来说,癌症治疗的启动经常会被推迟.
- 缺乏一致的通信道 (如电话接入) 是一个重要的障碍.
- 潜在的干预措施,例如提供基本的沟通工具,可能有助于减轻延迟.
相关概念视频
Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...


